Executive Management

Craig T. Davenport
CEO

Mr. Davenport has over 35 years of experience in the health care industry and has a proven track record of leading, building, managing and investing in rapidly growing medical device technology companies. He has served as a Director on the Board for 18 early stage or emerging growth healthcare companies.

Recently, he was Chairman, President & CEO of Endocare and over six years built the company into a leading provider of minimally invasive technologies to treat prostate, kidney, lung and other cancers using cryotherapy. Earlier in his career, Mr. Davenport was C.O.O & President of Tokos Medical Corporation when it was an early stage medical device manufacturer and clinical services provider, and over nine years he spearheaded the company's growth from a handful of people to more than 3,000 employees, took the Company public in 1990 and grew revenues from $3.7 million to more than $120 million. Mr. Davenport began his career with American Hospital Supply Corporation.

In addition to his management and leadership experience, most recently, Mr. Davenport was CEO & Managing Partner of the D.W. Group a private investment firm he founded in 1993. Over the years the firm has been an active investor in numerous early stage and emerging growth healthcare companies. Some of the investments made through the D. W. Group have included Vescia Medical (sold to Boston Scientific), Sapient Health Network (sold to WebMD), Cohesion Technologies (sold to AngioTech) and Paradigm Health Services (sold to Inverness Medical).

Kevin M. Quilty
Vice President for Global Sales and Marketing
Mr. Quilty has been a driving force behind the success of multiple medical device and healthcare service companies for over 35 years. Most recently, he served as CEO of Bioseal a privately held medical device manufacturer of custom single-use items used in the operating room, surgery centers and hospitals. Previously he served as Senior Vice President of Sales & Marketing as well as Chief Operating Officer for Endocare, Inc. Mr. Quilty developed the global strategy that successfully launched cryoablation technology for the treatment of prostate cancer and ablation of tumors in kidney, lung, liver and bone. Mr. Quilty built a global sales and marketing team of 50 individuals that generated revenue of $32 million.

Mr. Quilty was also Executive Vice President of Market Operations and Sales for Pointshare Corporation where he pioneered online business services. As Senior Vice President of Sales and Marketing for Paidos Health Management Services, he catapulted revenue by 45% by cultivating new markets in New York, Connecticut, Florida, and Texas. Mr. Quilty spearheaded joint ventures with leading academic centers as Chief Executive Officer of Qaulidx, LLC.

Mr. Quilty holds a Bachelor of Science degree in political science from the State University of New York at Oneonta.

Mike Poelking
Vice President of Finance, CFO
Mr. Poelking has more than 30 years experience in finance and operations and has most recently worked in the healthcare industry. He has performed in public, private and venture backed companies where he's gained experience in medical device and medical imaging sectors. Recently he was the Senior VP and CFO for Inviro Medical where he was responsible for coordinating the commercialization funding and contributed to the recruitment of the sales and clinical teams for a successful product launch. He has a broad experience base including implementing cost management initiatives, exploiting new growth opportunities, resource allocation, cost accounting and strategic planning. Mr. Poelking graduated from Loyola University with a Master of Business Administration.

Steven Todd Gold, Esq. J.D.,M.P.H.,M.B.E.
General Counsel & Vice President of Business Development
Mr. Gold provides in-house legal counsel to the company in addition to his position as the Vice President of Business Development. Mr. Gold is the primary contact for all corporate partnerships and other high level relationships for the Company. In addition to his legal background, Mr. Gold has extensive experience in private company formation, funding, and development of successful exit strategies. A graduate of Yale University (B.A.), the University of Florida Levin School of Law (J.D.), the University of Florida College of Medicine (M.P.H.) and the University of Pennsylvania School of Medicine Center for Bioethics (M.B.E.), Mr. Gold has previously served in the chambers of Justice Charles Wells of the Florida Supreme Court and has worked as a Deputy Solicitor General for the Florida Attorney General. He is barred in Florida, New Jersey and a number of appellate courts, including the United States Supreme Court.

Kim Barkman, BSN, MSIT, MBA
Vice President of Customer Advocacy, System Development & Management
Ms. Barkman has extensive Healthcare industry experience with a focus on the blending of Healthcare and Technology. Her background as a registered nurse in Critical Care environments lead to an interest in Clinical Information Systems.  Various Healthcare Informatics roles at Orlando Health have included Management Engineering using Six Sigma methodology, IT Project Management with certification and IT consulting.  Responsibilities included identifying ways that IT can improve workflow with a concentration on benefits realization as well as an emphasis on understanding core business processes in preparing for the implementation of technological solutions.  She worked for a number of years in the Australian Healthcare system before returning to the US to serve as the Director of Clinical Informatics/Development at the Aetna Specialty Pharmacy and then as Director of Business Intelligence/Data Warehousing with Adventist Healthcare system.  She received her BSN degree from the University of Florida, MSIT from Barry University and her MBA with focus in Marketing from Webster University.  She has been awarded National Board Certification as an Informatics Nurse. 

Ronald E. Youngblood II, B.S.
Vice President of Operations
Mr. Youngblood is a graduate of the University of Florida, with a degree in Resource Economics. He has over 25 years of manufacturing experience, spanning all aspects from planning and hands-on development to managing processes and associates. Mr. Youngblood spent 14 years with Honeywell International, primarily with Honeywell’s Guidance and Navigation Operations center in Clearwater, Florida. There, he was responsible for development and manufacture of inertial guidance systems with embedded GPS capability that are currently in use on a multitude of aircraft and missiles worldwide. While at Honeywell, Mr. Youngblood was trained and certified as an expert in Demand Flow and Lean Manufacturing, and completed extensive specialized training in Root Cause and Corrective Action processes.

In 1998, Mr. Youngblood joined the startup company Regeneration Technologies, Inc. in Alachua, Florida and became Manager of Spinal Allograft Manufacturing, reporting directly to the Vice President of Operations. In 2000 Mr. Youngblood supported a successful IPO that helped position RTI as a world leader in the biomedical industry. During his tenure, he managed all aspects of biomedical manufacturing in both human and bovine production from initial concept through product launch utilizing state of the art machining, a highly skilled staff and the trademarked Biocleanse sterilization process.

In 2006, Mr. Youngblood joined the startup company Xhale Inc. in Gainesville, Florida and became Vice President of Operations reporting directly to the CEO. Mr. Youngblood has been instrumental in the product development and commercialization of both Xhale Inc. and HyGreen lines and oversees all Engineering , Manufacturing and Installation activities on a national level.

Richard J. Melker, M.D., Ph.D.
Chief Technology Officer
Dr. Melker, co-founder and Chief Technology Officer with Xhale, received his Ph.D. (Neurobiology) and M.D. degrees from Albert Einstein College of Medicine. After a residency in Pediatrics, and fellowships in Pediatric Cardiology and Critical Care Medicine, he served as Director of Emergency Services at Shands Hospital at the University of Florida College of Medicine, as well as Medical Liaison for the NASA space shuttle program. He holds the position of Professor of Anesthesiology, Pediatrics and Biomedical Engineering at U.F. and since 1993 has been Director of the Florida Anesthesiology Computer and Engineering Team (FACET) which develops and licenses medical devices and technologies. Dr. Melker holds over 35 issued U.S. patents including several for emergency medical devices in use throughout the world, and by the U.S. Special Forces.

Donn Dennis, M.D., F.A.H.A., CSO
Chief Science Officer
Dr. Dennis, co-founder of Xhale with Mr. Allen and Dr. Melker, serves as the company's Chief Science Officer. He is a board certified anesthesiologist, and previously served as Vice President of Pharmacology at ARYx Therapeutics in Fremont, CA.. In addition to his work with Xhale, Dr. Dennis is a professor in the Departments of Anesthesiology, Psychiatry and Pharmacology & Experimental Therapeutics in the College of Medicine at the University of Florida (U.F.), where he also holds the Joachim S. Gravenstein M.D. Endowed Chair in Anesthesiology. He is also the Director of Nanomedicine at the University of Florida.

Dr. Dennis' research interests focus on translating fundamental science findings in the areas of cardiovascular biology and nanotechnology into medically useful, commercially viable products (e.g., new chemical entities, nano-based drug delivery systems and sensors). He has a long track record of R&D experience, including co-developing drugs and consulting with several small, medium and large pharmaceutical companies and large biotech and health care venture capital funds. Dr. Dennis has been the recipient or co-recipient of several federal grants in the areas of bionanotechnology and cardiovascular pharmacology, and is a co-inventor on several drug- and bio-nano patent applications. Dr. Dennis has published over 150 full length manuscripts and abstracts in peer reviewed journals and has edited two textbooks. He is also a regular member of NSF Nanoscale Science and Engineering Center (NSEC) site visit teams. Dr. Dennis was recently elected to the Board of Directors of the Foundation for Anesthesia Education & Research FAER). He received his medical degree during 1986 from the University of Michigan.

Hank Wohltjen, Ph.D.
Vice President of Engineering - Xhale, Inc.
Dr. Wohltjen focuses on applying the latest advances in microsensor technologies to the analysis of exhaled breath as a diagnostic matrix. Trained as both an electrical engineer and a chemist, Dr. Wohltjen has been actively engaged in the development and commercialization of novel chemical sensing devices and systems since 1976. In the 1980’s he formed the Chemical Microsensor research group at the US Naval Research Lab that pioneered a number of important advances in chemical sensor technology. Later he founded Microsensor Systems, Inc. (MSI) and led the commercial development of Surface Acoustic Wave (SAW) microsensors for detecting chemical warfare threats. Over the years Dr. Wohltjen has been the principal investigator on more than $10M of federally funded sensor R&D programs. In 1995 his previous company, MSI, was recognized with the Tibbetts Award from the US Small Business Administration for its successful participation in numerous SBIR programs. Presently Dr. Wohltjen also serves as a director on several boards of academic institutions and small technology-focused companies.

Elena Fraser, MBA
Director of Marketing
Elena Fraser has more than 20 years of experience in the marketing and design.  At Xhale, Ms. Fraser is the Director of Marketing for HyGreen and manages Business Development and Marketing for the Xhale’s pharmaceutical division.  She was with the University of Florida for over 17 years in the College of Public Health and Health Professions and was the project manager for the Rehabilitation Engineering Research Center.   Her last four years were as director of the International Conference on Aging and Disability, bringing researchers, academicians and policy leaders from all over the world to discuss the issues of aging and disability. Over the years, Ms. Fraser has edited 29 publications, co-authored five manuscripts, and written 17 successful grant applications.  She has also volunteered marketing and PR services to several charities including Sustainable Cambodia, the NACD and Rotary.